IL151772A0 - Methods for producing pneumococcal capsular polysaccharide - Google Patents

Methods for producing pneumococcal capsular polysaccharide

Info

Publication number
IL151772A0
IL151772A0 IL15177201A IL15177201A IL151772A0 IL 151772 A0 IL151772 A0 IL 151772A0 IL 15177201 A IL15177201 A IL 15177201A IL 15177201 A IL15177201 A IL 15177201A IL 151772 A0 IL151772 A0 IL 151772A0
Authority
IL
Israel
Prior art keywords
methods
capsular polysaccharide
pneumococcal capsular
test compound
producing
Prior art date
Application number
IL15177201A
Other languages
English (en)
Original Assignee
Philadelphia Children Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22699002&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IL151772(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Philadelphia Children Hospital filed Critical Philadelphia Children Hospital
Publication of IL151772A0 publication Critical patent/IL151772A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
    • C12Q1/18—Testing for antimicrobial activity of a material

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
IL15177201A 2000-03-16 2001-03-16 Methods for producing pneumococcal capsular polysaccharide IL151772A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US18984700P 2000-03-16 2000-03-16
PCT/US2001/008442 WO2001068903A1 (en) 2000-03-16 2001-03-16 Modulating production of pneumococcal capsular polysaccharide

Publications (1)

Publication Number Publication Date
IL151772A0 true IL151772A0 (en) 2003-04-10

Family

ID=22699002

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15177201A IL151772A0 (en) 2000-03-16 2001-03-16 Methods for producing pneumococcal capsular polysaccharide
IL151772A IL151772A (en) 2000-03-16 2002-09-15 Processes for the preparation of a phenococcal capsular polysaccharide
IL191962A IL191962A (en) 2000-03-16 2008-06-05 Method for assessing if a test compound is useful for alleviating a pneumococcal infection

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL151772A IL151772A (en) 2000-03-16 2002-09-15 Processes for the preparation of a phenococcal capsular polysaccharide
IL191962A IL191962A (en) 2000-03-16 2008-06-05 Method for assessing if a test compound is useful for alleviating a pneumococcal infection

Country Status (19)

Country Link
US (1) US6642017B2 (el)
EP (2) EP1268844B1 (el)
JP (1) JP4856345B2 (el)
KR (3) KR100942738B1 (el)
CN (2) CN101586143A (el)
AT (1) ATE437955T1 (el)
AU (2) AU2001245795B2 (el)
BR (1) BRPI0109293B8 (el)
CA (1) CA2403001C (el)
CY (1) CY1109418T1 (el)
DE (1) DE60139384D1 (el)
DK (1) DK1268844T3 (el)
ES (1) ES2330919T3 (el)
HK (1) HK1055448A1 (el)
IL (3) IL151772A0 (el)
MX (1) MXPA02009047A (el)
NZ (1) NZ521343A (el)
PT (1) PT1268844E (el)
WO (1) WO2001068903A1 (el)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101586143A (zh) * 2000-03-16 2009-11-25 费城儿童医院 调节肺炎球菌荚膜多糖的生产
US7709001B2 (en) * 2005-04-08 2010-05-04 Wyeth Llc Multivalent pneumococcal polysaccharide-protein conjugate composition
EP3466982B1 (en) * 2005-04-08 2020-06-17 Wyeth LLC Separation of contaminants from streptococcus pneumoniae polysaccharide by ph manipulation
US7491517B2 (en) * 2006-07-19 2009-02-17 Jeeri R Reddy Method of producing meningococcal meningitis vaccine for Neisseria meningitidis serotypes A,C,Y, and W-135
ES2346929T3 (es) * 2006-10-10 2010-10-21 Wyeth Llc Procedimientos mejorados para la separacion de polisacaridos de streptococcus pneumoniae de tipo 3.
WO2009059054A2 (en) * 2007-10-30 2009-05-07 The Trustees Of The University Of Pennsylvania Bacteria strains an d bacteriocin produced therefrom
HUE037465T2 (hu) * 2008-12-18 2018-09-28 Wyeth Llc Eljárás 19A szerotípusú streptococcus pneumoniae poliszacharidok molekulatömegének szabályozására
PL2385981T3 (pl) 2008-12-18 2020-01-31 Wyeth Llc Sposób kontroli masy cząsteczkowej polisacharydów streptococcus pneumoniae z zastosowaniem węgla
CN102093963B (zh) * 2010-11-26 2012-11-14 兰州生物制品研究所有限责任公司 富含磷壁酸的肺炎链球菌的培养方法
US10150979B2 (en) 2014-05-07 2018-12-11 Glaxosmithkline Biologicals Sa Purification of secreted polysaccharides from S. agalactiae
WO2016019167A1 (en) 2014-07-31 2016-02-04 Corning Incorporated Thermally tempered glass and methods and apparatuses for thermal tempering of glass
US10611664B2 (en) 2014-07-31 2020-04-07 Corning Incorporated Thermally strengthened architectural glass and related systems and methods
US11097974B2 (en) 2014-07-31 2021-08-24 Corning Incorporated Thermally strengthened consumer electronic glass and related systems and methods
WO2017123573A2 (en) 2016-01-12 2017-07-20 Corning Incorporated Thin thermally and chemically strengthened glass-based articles
US11795102B2 (en) 2016-01-26 2023-10-24 Corning Incorporated Non-contact coated glass and related coating system and method
WO2019040818A2 (en) 2017-08-24 2019-02-28 Corning Incorporated GLASSES HAVING ENHANCED TEMPERATURE CAPABILITIES
TWI785156B (zh) 2017-11-30 2022-12-01 美商康寧公司 具有高熱膨脹係數及對於熱回火之優先破裂行為的非離子交換玻璃
WO2019142848A1 (ja) * 2018-01-22 2019-07-25 一般財団法人阪大微生物病研究会 肺炎球菌試料の培養用培地
US12064938B2 (en) 2019-04-23 2024-08-20 Corning Incorporated Glass laminates having determined stress profiles and methods of making the same
KR20220044538A (ko) 2019-08-06 2022-04-08 코닝 인코포레이티드 균열을 저지하기 위한 매장된 응력 스파이크를 갖는 유리 적층물 및 이를 제조하는 방법

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2510606A1 (fr) * 1981-07-30 1983-02-04 Berri Balzac Procede d'obtention de polyosides capsulaires, polyosides capsulaires ainsi obtenus et leur application a la preparation de vaccins
CA2116261A1 (en) * 1993-04-20 1994-10-21 David E. Briles Epitopic regions of pneumococcal surface protein a
AU2638595A (en) * 1994-05-16 1995-12-05 Uab Research Foundation, The (streptococcus pneumoniae) capsular polysaccharide genes and flanking regions
CN101586143A (zh) * 2000-03-16 2009-11-25 费城儿童医院 调节肺炎球菌荚膜多糖的生产

Also Published As

Publication number Publication date
EP1967591A2 (en) 2008-09-10
IL151772A (en) 2009-12-24
ATE437955T1 (de) 2009-08-15
WO2001068903A1 (en) 2001-09-20
MXPA02009047A (es) 2005-04-19
DK1268844T3 (da) 2009-11-16
AU4579501A (en) 2001-09-24
KR100942738B1 (ko) 2010-02-17
CN100529054C (zh) 2009-08-19
EP1967591A3 (en) 2008-12-03
KR20030040196A (ko) 2003-05-22
KR20080036656A (ko) 2008-04-28
JP4856345B2 (ja) 2012-01-18
CN101586143A (zh) 2009-11-25
HK1055448A1 (en) 2004-01-09
CA2403001C (en) 2012-07-03
EP1268844B1 (en) 2009-07-29
IL191962A (en) 2010-12-30
DE60139384D1 (de) 2009-09-10
CN1429276A (zh) 2003-07-09
EP1268844A4 (en) 2006-03-29
US6642017B2 (en) 2003-11-04
CY1109418T1 (el) 2014-08-13
BRPI0109293B1 (pt) 2015-05-19
BRPI0109293B8 (pt) 2021-05-25
EP1268844A1 (en) 2003-01-02
AU2001245795B2 (en) 2005-07-28
PT1268844E (pt) 2009-11-03
BR0109293A (pt) 2003-06-10
CA2403001A1 (en) 2001-09-20
KR100914702B1 (ko) 2009-08-28
NZ521343A (en) 2005-03-24
US20030021811A1 (en) 2003-01-30
JP2003531584A (ja) 2003-10-28
ES2330919T3 (es) 2009-12-17
IL191962A0 (en) 2008-12-29
KR20080081978A (ko) 2008-09-10

Similar Documents

Publication Publication Date Title
IL151772A0 (en) Methods for producing pneumococcal capsular polysaccharide
AR248168A1 (es) Metodo y aparato para producir un tetrasacarido y alimento que lo comprende.
WO2003028576A3 (en) Method and apparatus for dental implants
DE3687402D1 (de) Thrombinzusammensetzung.
TR200000338T2 (tr) Polietilen'in hazırlanmasına mahsus bir yöntem.
DE122011100030I1 (de) Polyribosylribitol-phosphat enthaltende Haemophilus-influenzae-Typ -b-Impfstoffzubereitung und Verfahren zur deren Herstellung.
BG94868A (bg) Мутант на бактерията сlоsтrifiuм нisтоlyтiсuм, метод за получаването му и използуването му за производство на свободна от клострипаин колагеназа
ATE80524T1 (de) Gefrorenes produkt und herstellungsverfahren.
TW358099B (en) Process for the synthesis of crysteamine melaminylthioarsenate dihydrochloride or melarsomine dyhydro-chloride
WO1996032109A3 (en) Levobupivacaine and its use as an anaesthetic in pregnant women
ATE197645T1 (de) Immunoenzymatisches konjugat, herstellungsverfahren dafür und verwendungen
DE3873128D1 (de) Verfahren zur herstelung eines elektrischen uebertragungslinie.
EP0761686A3 (en) Anticoagulant factor Va derivatives
ID28174A (id) Turunan 5-imino-13-deoksi antrasiklin, penggunaannya, dan proses pembuatannya
DE3689855D1 (de) Rhizobium-Impfstoffe.
DK0809653T3 (da) Helicobacter pylori-antigen
UA31867A (uk) Спосіб лікування хворих на гострі виразки шлунку, ускладнені кровотечею
BG40817A3 (en) Method for preparation of macrolidic antibiotics
FR2631976B1 (fr) Polyglycannes hydrosolubles possedant notamment des proprietes viscosantes
DE3772612D1 (de) Entschaeumergemisch.
YU52602A (sh) Postupak za pripremanje estara aril-iminometil-karbaminske kiseline
UA49675A (uk) Спосіб лікування орнітозної пневмонії
RU2002133737A (ru) Способ лечения бруцеллеза, включающий пероральное применение иммуномодулятора, иммобилизованного в липосому
UA33944A (uk) Спосіб інтраопераційної рн-метрії